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Neutrophil degranulation plays an important role in
acute innate immune responses and is tightly regu-
lated because the granule contents can cause tissue
damage. However, this regulation remains poorly un-
derstood. Here, we identify the complex of STK24
and CCM3 as being an important regulator of neutro-
phil degranulation. Lack of either STK24 or CCM3 in-
creases the release of a specific granule pool without
affecting other neutrophil functions. STK24 appears
to suppress exocytosis by interacting and competing
with UNC13D C2B domain for lipid binding, whereas
CCM3 has dual roles in exocytosis regulation.
Although CCM3 stabilizes STK24, it counteracts
STK24-mediated inhibition of exocytosis by recruit-
ing STK24 away from the C2B domain through its
Ca2+-sensitive interactionwith UNC13DC2A domain.
This STK24/CCM3-regulated exocytosis plays an
important role in the protection of kidneys from
ischemia-reperfusion injury. Together, these findings
reveal a function of the STK24 and CCM3 complex in
the regulation of ligand-stimulated exocytosis.
INTRODUCTION
Serine/threonine protein kinase (STK) 24 (also known as
mammalian sterile 20-like kinase 3 [MST3]), MST4, and STK25
belong to the germinal center kinase (GCK) III subfamily of sterile
20 kinases (Pombo et al., 2007). These GCKIII subfamily kinases
have been implicated in regulating a number of cellular functions
(Schinkmann and Blenis, 1997; Huang et al., 2002; Irwin et al.,
2006; Lu et al., 2006; Wu et al., 2008, 2011; Lorber et al., 2009;
Fidalgo et al., 2010) and interact with CCM3 (also known as pro-
grammed cell death 10 [PDCD10]) (Rual et al., 2005; FidalgoDevelopmet al., 2010; Zheng et al., 2010; Ceccarelli et al., 2011; Kean
et al., 2011). Mutations in the CCM3 gene as well as in two other
structurally unrelated genes, CCM1 and CCM2, were found in
the familial forms of cerebral cavernous malformations (CCM)
(Faurobert and Albiges-Rizo, 2010; Cavalcanti et al., 2012).
CCM is a vascular pathological condition that affects the vascu-
lature of the central nervous system and results in stroke, seizure
and cerebral hemorrhage with a high prevalence. CCM3 has two
domains—an N-terminal domain and a C-terminal focal adhe-
sion targeting homology (FATH) domain. GlobalCcm3 disruption
resulted in embryonic lethality probably due to defects in the car-
diovascular system (He et al., 2010). STK24 and STK25 also
appear to function in the same pathway as CCM3 in cardiovas-
cular development (Voss et al., 2009; Fidalgo et al., 2010; Zheng
et al., 2010; Yoruk et al., 2012). However, the underlying
biochemical mechanisms for howGCKIII kinases or CCM3 regu-
late these functions are still poorly understood.
Exocytosis occurs in every cell and is a process by which a cell
directs the contents (secreted proteins, membrane proteins, and
lipids) of secretory vesicles toward extracellular space. Neutro-
phils play important roles in innate immunity and utilize a regu-
lated exocytic process of degranulation to execute some of their
functions. Degranulation results in the releases of various prote-
ases and other cytotoxic agents, including matrix metalloprotei-
nases (MMPs) and myeloperoxidase (MPO) (Lacy and Eitzen,
2008). These granule contents are antimicrobial, but can also
cause tissue damage and organ failure during ischemia-reperfu-
sion that occurs in stroke or organ transplantation and during
adapted immune responses in chronic inflammation and viral
infections (Lacy and Eitzen, 2008).
Exocytosis is accomplished by the fusion of secretory vesicles
with the plasma membrane through the assembly of the SNARE
complex. Before membrane fusion, additional proteins mediate
and regulate the initial interaction between the vesicles and
the acceptor membrane. They include the Rab family of
small GTPases, the exocyst, and numerous other regulatory pro-
teins (Sugita, 2008; He and Guo, 2009; Su¨dhof and Rizo, 2011;
Jahn and Fasshauer, 2012). Among these regulatory proteins isental Cell 27, 215–226, October 28, 2013 ª2013 Elsevier Inc. 215
Figure 1. STK24 Deficiency Increases
Neutrophil Degranulation
(A) Verification of STK24 deficiency in neutrophils.
Neutrophils were isolated from WT and Stk24h/h
mice and analyzed by western analysis using
antibodies specific to STK24, MPO or Gb2. See
also Figure S1A.
(B) Lack of an effect of STK24 deficiency on the
number of circulating leukocytes. PMN, neutro-
phils; MN, monocytes; LY, lymphocytes. The data
are presented as means ± SD.
(C–E) Lack of an effect of STK24 deficiency on
chemotactic activities. Chemotactic responses of
neutrophils were examined using a Dunn chamber
containing an fMLP gradient. The data are pre-
sented as means ± SD.
(F) Lack of an effect of STK24 deficiency on super-
oxide production upon stimulation by 1 mM fMLP.
(G) Lack of an effect of STK24 deficiency on
phagocytosis of opsonized E. coli. The data are
presented as means ± SD.
(Hand I) IncreasedsecretionofMMPandMPOfrom
Stk24h/h neutrophils. Neutrophils were stimulated
with 500 nM fMLP or 10 nMMIP2. The experiments
were repeated three times. The data are presented
as means ± SD (*p < 0.05, Student’s t test).
(J) Suppression of MPO secretion by STK24
expression in Stk24h/h neutrophils. Stk24h/h neu-
trophils were transfected with GFP, GFP-STK24
(STK) or GFP-STK24-K53R (KR) plasmids, and
GFP-positive cells were isolated by FACS. Cells
were then stimulated with 500 nM fMLP and
assayed for MPO secretion. The data are pre-
sented as means ± SD (*p < 0.05, Student’s t test;
n = 3). See also Figure S1B.
Developmental Cell
STK24 and CCM3 Regulate Exocytosisthe UNC13 (Munc13) family of proteins, which consists of
UNC13A-D (Koch et al., 2000; Feldmann et al., 2003). UNC13D
(also known as Munc13-4), which is expressed at high levels in
hematopoietic cells, contains two separate C2 domains (C2A
and C2B) and two Munc13-homology domains (MHD1 and
MHD2) (Fukuda, 2005). UNC13D binds to RAB27, through which
it is tethered to vesicles, and also binds to syntaxins and DOC2a
(Higashio et al., 2008; Boswell et al., 2012). Syntaxins are com-
ponents of SNARE complexes, which are involved in membrane
fusion, whereas DOC2a is an exocytosis regulator. Both human
and mouse genetic evidence has established an important role
of UNC13D in the regulation of exocytosis in cytotoxic T cells,
mast cells, platelets, and neutrophils (Feldmann et al., 2003; Cro-
zat et al., 2007; Brzezinska et al., 2008; Pivot-Pajot et al., 2008;
Ren et al., 2010; Elstak et al., 2011). UNC13D is involved in
granule tethering to plasma membranes through the binding of
its C2B domain to membrane lipids during granule docking
and priming SNARE-mediated fusion (Me´nager et al., 2007; de
Saint Basile et al., 2010; Elstak et al., 2011; Boswell et al., 2012).
Exocytic vesicles or granules exist in different forms, many of
which are released in a controlled manner, often by extracellular
stimuli. Ligand-stimulated exocytosis, which neutrophil degran-
ulation is a form of, plays important roles in various philological
and pathophysiological processes. A great deal of knowledge
has been gained on how ligands stimulate exocytosis particu-
larly through Ca2+ over the years (Pang and Su¨dhof, 2010; Par-
ekh, 2011; Yamashita, 2012). There appear to be at least two216 Developmental Cell 27, 215–226, October 28, 2013 ª2013 Elsevpools of exocytic granules that correspond to the two phases
of exocytosis observed upon ligand stimulation. One pool is
docked/primed and readily releasable. The other one is nonread-
ily releasable or reserved, which is not docked/primed before
stimulation and has to undergo docking/priming upon stimula-
tion (Sugita, 2008; Pores-Fernando and Zweifach, 2009; Seino
et al., 2011). In our investigation of the roles of STK24 and
CCM3 in regulation of neutrophil functions, we unexpectedly
discovered the STK24 and CCM3 complex as being a regulator
of ligand/Ca2+-stimulated exocytosis that regulates the second
phase of degranulation in neutrophils. We elucidated the mech-
anisms by which STK24 and CCM3 regulate the exocytic pro-
cess through their interactions with UNC13D and demonstrated
that CCM3 and STK24-regulated exocytosis play an important
role in tissue injury protection. These results together have re-
vealed physiological and cellular roles of STK24 and CCM3
and provided mechanistic insights into ligand-regulated degran-
ulation/exocytosis.
RESULTS
STK24 Deficiency Enhances Degranulation
The Stk24 gene is expressed at a high level in human neutrophils
(Payton et al., 2009), and its protein was readily detected in
mouse neutrophils (Figure 1A). To investigate the importance
of Stk24 in neutrophils, a Stk24mutant mouse line was acquired
from the International Gene Trap Consortium. In this mouse line,ier Inc.
Figure 2. STK24 Regulates the Release of
the Reserved Pool of Granules
(A) Colocalization of STK24 and MPO in mouse
neutrophils. Mouse neutrophils were stained for
STK24 and MPO and detected by a confocal
microscope. Single optical sections are shown.
(B) Lack of an effect of STK24 deficiency on the
number of MPO-containing granules in resting
neutrophils. Mouse neutrophils were stained for
MPO and imaged using a TIRF microscope. The
number of granules from 25 WT and mutant cells
was counted and is presented as means ± SD
(Student’s t test, n > 50). See also Figure S2A.
(C–E) STK24 deficiency increases granule fusion
events upon a follow-up stimulation. Individual
WT and STK24-deficient neutrophils expressing
VAMP8-pHluorin were stimulated with one puff
of fMLP (10 mM) and CB (10 mM) from a micropi-
pette (initial stimulation). Four minutes later, the
neutrophils were stimulated with a follow-up puff (follow-up stimulation). Time-lapsed images were acquired using a TIRF microscope. Representative image
series of single granule fusions are shown in (C). The image time interval is 200 ms. The durations of individual granule fusions for the initial and follow-up
stimulations (D) are quantified, and the numbers of fusion events in per neutrophil after the initial stimulations and follow-up stimulations (E) are counted. Data are
presented as means ± SD (*p < 0.05, Student’s t test; n = 9). See also Figure S2B.
(F) Time-dependent effects of STK24 deficiency on MPO release. WT and STK-deficient neutrophils were treated with 500 nM fMLP and assayed for MPO
secretion at different time points. Data are presented as means ± SD (*p < 0.05; ^p > 0.1, Student’s t test, n = 3). See also Figure S2C.
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STK24 and CCM3 Regulate ExocytosistheStk24 genewas disrupted by an insertion, resulting in a hypo-
morphic allele (Figure S1A available online). The mice homozy-
gous for this hypomorphic allele, designated as Stk24h/h, were
viable and showed no gross phenotypes. The STK24 protein
content in the Stk24h/h neutrophils is greatly reduced (by more
than 90%) (Figure 1A). STK24 deficiency did not appear to affect
the numbers of neutrophils or other leukocytes including mono-
cytes or lymphocytes in the peripheral blood (Figure 1B). Addi-
tionally, STK24 deficiency did not cause significant alterations
in the ability of the neutrophils to chemotax (Figures 1C–1E),
produce superoxide (Figure 1F), or phagocytose (Figure 1G),
compared to those isolated from the wild-type (WT) littermates.
However, we found that Stk24h/h neutrophils released signifi-
cantly greater amounts of myeloperoxidase (MPO) (Figure 1H)
and matrix metalloproteinases (MMPs) (Figure 1I) than the WT
cells did in response to the stimulation of chemoattractant
fMLP or MIP2. The MPO protein contents in WT and Stk24h/h
neutrophils are similar (Figure 1A). Thus, these results suggest
that the lack of STK24may result in enhanced neutrophil degran-
ulation. In support of this conclusion, expression of STK24-GFP
fusion protein in the Stk24h/h neutrophils reduced MPO release
(Figure 1J). Because expression of a kinase-dead mutant of
STK24 (K53R) at a level similar to that of WT STK24-GFP (Fig-
ureS1B) also led to a similar reduction inMPO release (Figure 1J),
STK24 probably regulates degranulation through a kinase activ-
ity-independent mechanism.
STK24 Regulates the Release of a Specific Pool of
Granules
Immunostaining of mouse neutrophils with an anti-STK24
antibody revealed a punctate pattern of STK24 subcellular local-
ization, suggesting that STK24 may primarily be localized with
granules (Figure 2A). Costaining with an anti-MPO antibody
showed that most of the MPO-positive granules were STK24-
positive, whereas about a quarter of STK24-positive granules
were MPO positive. Because neutrophils are known to containDevelopmdifferent types of granules, a fraction of which contains MPO
(Lacy and Eitzen, 2008), these results suggest that STK24 may
be involved in the regulation of different types of granules. This
concept is consistent with the finding that STK24 deficiency is
also associated with increased release of MMP (Figure 1I), which
is in a different type of granules from those containingMPO (Lacy
and Eitzen, 2008). Using confocal microscopy, we compared the
number of MPO-positive granules in WT and STK24-deficient
neutrophils and found no significant difference (data not shown).
We also compared the number of MPO-positive granules in
close proximity (<200 nm) to plasma membranes as detected
by the total internal reflection fluorescence (TIRF) microscopy
(Figure S2A) and again observed no significant difference
between WT and Stk24h/h neutrophils (Figure 2B).
To further investigate the degranulation process, we visualized
and compared the fusion processes of individual granules in the
WT and Stk24h/h neutrophils using live-cell TIRFmicroscopy. We
have previously used the fusion protein of the v-SNARE vesicle-
associated membrane protein 2 (VAMP2) with a pH-sensitive
fluorescent protein, pHluorin, to monitor the exocytosis of
GLUT4 storage vesicles (Xu et al., 2011). The fluorescence of
pHluorin becomes much brighter when transferred from an
acidic (inside vesicles) to a neutral environment (after vesicle
fusion with the plasma membrane) (Miesenbo¨ck et al., 1998;
Jankowski et al., 2001; Sankaranarayanan and Ryan, 2001).
Although VAMP2 is not associated with MPO-positive vesicles
(data not shown), VAMP8 is (Figure S2B). We expressed
VAMP8-pHluorin in neutrophils and locally stimulated each indi-
vidual neutrophil by fMLP using a micropipette. Shortly after the
stimulation, there was an increase in the number of ‘‘flashes’’ as
the result of a sudden increase in fluorescence upon granule
fusion and dissipation of fluorescence due to lateral diffusion
of the VAMP molecules in the plasma membrane after granule
fusion (Figure 2C). Quantitative analysis of fusion events
revealed no significant differences in either the total number
of fusion events or the kinetics of each fusion event betweenental Cell 27, 215–226, October 28, 2013 ª2013 Elsevier Inc. 217
Figure 3. CCM3 Deficiency Increases
Neutrophil Degranulation
(A) Colocalization of CCM3 and STK24 in mouse
neutrophils. A representative neutrophil express-
ing GFP-STK24 and CCM3-mCherry was de-
tected by a confocal microscope. Single optical
sections are shown.
(B) Validation of CCM3 deficiency in Ccm3m/m
neutrophils. Ccm3m/m neutrophils were analyzed
by western using an antibody to CCM3, STK24,
or Gb2.
(C and D) Increased secretion of MMP and
MPO fromCcm3m/m neutrophils. Neutrophils were
stimulated with 500 nM fMLP or 10 nM MIP2. The
data are presented as means ± SD (*p < 0.05,
n = 3, Student’s t test). See also Figure S3.
(E–H) Effects of CCM3 deficiency on granule
fusion. Cells were treated and analyzed as in
Figure 1. The data are presented as means ± SD
(*p < 0.05; Student’s t test, n = 9).
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STK24 and CCM3 Regulate ExocytosisWT or Stk24h/h neutrophils after the initial stimulation (Figures 2D
and 2E).
Two types of secretory granules have been described. One is
docked/primed and readily releasable. The other is nonreadily
releasable or reserved, which is not docked/primed before stim-
ulation and has to undergo docking/priming upon activation
(Sugita, 2008; Pores-Fernando and Zweifach, 2009; Seino
et al., 2011). We thus investigated whether STK24 deficiency
might affect the granule release from this reserved pool. We first
examined the time course of MPO release upon uniform stimula-
tion. Although there was no significant difference in the MPO
release between WT and Stk24h/h neutrophils after 1 min stimu-
lation, significant differences were observed after longer stimula-
tions (Figure 2F), suggesting that STK24 may be involved in
regulating the release of the reserved pool of granules. To further
corroborate this conclusion, we performed sequential stimula-
tions in the live TIRF experiment using micropipettes to tran-
siently stimulate the cells. When the cells were stimulated at
4 min after the initial stimulation, we observed a significant in-
crease in the number of granule fusion events in STK24-deficient
neutrophils compared to that in WT neutrophils in response to
this follow-up stimulation (Figure 2E), even though there was
no significant difference in the fusion kinetics between WT and
mutant neutrophils (Figure 2D). When the follow-up stimulations218 Developmental Cell 27, 215–226, October 28, 2013 ª2013 Elsevier Inc.were given 20 min after the initial stimula-
tions, the differences in fusion events
became less apparent (Figure S2C). We
interpret these results to suggest that
STK24 primarily suppresses the release
of the reserved pool of granules without
an apparent role in the release of docked
granules.
CCM3 Regulates Ligand-
Stimulated Exocytosis
STK24 forms a complex with CCM3 (Rual
et al., 2005; Zheng et al., 2010; Ceccarelli
et al., 2011; Kean et al., 2011). We
confirmed the interaction in a coprecipi-tation assay (data not shown). In mouse neutrophils, GFP-
STK24 is also colocalized with CCM3-mCherry (Figure 3A). To
investigate whether CCM3 has a role in neutrophil degranulation,
we generated myeloid-specific CCM3-deficient mice (Ccm3m/m)
by crossing floxed CCM3 mice with the B6.129-Lyzstm1(cre)Ifo/J
mice (Figure 3B). CCM3-deficient neutrophils also released
greater amounts of MPO and MMP in response to chemoattrac-
tants than those of WT neutrophils (Figures 3C and 3D). Our data
also confirmed a previous observation that CCM3 stabilized
STK24 (Fidalgo et al., 2010), because the amount of STK24 pro-
tein was reduced by more than 60% in CCM3-deficient neutro-
phils compared to that in WT neutrophils (Figure 3B). We also
examined VAMP8-positive granule fusion in CCM3-deficient
neutrophils using live-cell TIRF microscopy (Figure 3E). Similar
to what we observed with Stk24h/h neutrophils, CCM3 deficiency
increased the number of fusion events in response to the follow-
up stimulations compared to WT, without affecting the initial
responses or the fusion kinetics (Figures 3F–3H). Thus, we
concluded that CCM3 and STK24 function similarly in neutrophil
degranulation. Because neutrophils isolated from Stk24h/+ mice
showed enhanced MPO secretion (Figure S3A), the enhanced
exocytosis phenotype of CCM3 deficiency, which resulted in
more than one half reduction in STK24 protein content (Fig-
ure 3B), may at least in part be due to reduced STK24 protein
Figure 4. STK24 and CCM3 Interact with UNC13D
(A) Detection of the interactions by coimmunoprecipitation. HEK293 cells were
cotransfected with plasmids as indicated in the figure, and immunoprecipi-
tation was performed 24 hr later. Proteins were detected by western analysis.
See also Figure S4.
(B). Detection of the direct interactions by GST pull-down using recombinant
proteins isolated from E. coli. Proteins were detected by western analysis.
(C–E) STK24 and CCM3 do not interfere with the interaction of UNC13D with
RAB27, SYNTAXIN7, or DOC2a. HEK293 cells were cotransfected with plas-
mids as indicated, followed by immunoprecipitation and western analysis.
STX7, SYNTAXIN7.
Developmental Cell
STK24 and CCM3 Regulate Exocytosiscontent. Consistent with this conclusion, overexpression of
STK24 or CCM3, but not a CCM3 mutant (Figure S3B) that
cannot bind to STK24 (Figure S3C), was able to revert CCM3
deficiency-induced increase in MPO release. This conclusion is
further supported by the observation that overexpression of
CCM3 in wild-type neutrophils, which led to an increase in
STK24 protein, reduced MPO release (Figures S3D and S3E).
STK24 and CCM3 Interact with UNC13
To understand how STK24 and CCM3 regulate exocytosis, we
used the tandem affinity purification (TAP) technique, followed
by mass spectrometry, to identify proteins that may bind to
STK24 in HEK293. CCM3 was the top hit. Among the other
hits, there was UNC13B (Figure S4A). UNC13B (also known as
Munc13-2) is a member of the UNC13 family of exocytic regula-
tors (Koch et al., 2000; Feldmann et al., 2003; Li and Chin, 2003).
Although Unc13b is expressed at a very low level in neutrophils,
its family member Unc13d is expressed at a higher level in
neutrophils (Figure S4B). In addition, UNC13D (also known as
Munc13-4) has been shown to play a role in neutrophil degranu-
lation (Pivot-Pajot et al., 2008; Johnson et al., 2011). Thus, we
tested its interaction with STK24. UNC13D coimmunoprecipi-
tated with WT or kinase-dead STK24, when expressed in
HEK293 cells (Figure 4A). We also found that CCM3 and
UNC13D interacted by coimmunoprecipitation (Figure 4A). To
determine if these interactions are direct, recombinant proteins
were used in a pull-down assay. UNC13D interacted with
CCM3 as well as WT (Figure 4B) and kinase-dead (data not
shown) STK24.
The UNC13 family of proteins interacts with several exocy-
tosis-related proteins, including RAB27, DOC2a, and syntaxins
(STXs) (Neeft et al., 2005; Higashio et al., 2008; Boswell et al.,
2012). Given that STK24 regulates degranulation independently
of its kinase activity (Figure 1J), a possible mechanism for STK24
to inhibit exocytosis may be to disrupt one of these interactions
with UNC13D. However, expression of STK24 and/or CCM3 did
not attenuate the interaction of UNC13D with STX7, DOC2a, or
RAB27 (Figures 4C–4E).
STK24 Inhibits UNC13D Binding to Liposomes
UNC13D also binds with membrane lipids in a Ca2+-sensitive
manner and has an important role in vesicle docking and
SNARE-dependent vesicle fusion (Boswell et al., 2012). We
examined effects of STK24 and CCM3 on the binding of
UNC13D to lipids using buoyant density flotation of phosphati-
dylcholine (PC)/phosphatidylserine (PS) liposomes as previously
described (Boswell et al., 2012). Although CCM3 had little effect
on the binding of UNC13D to liposomes regardless of the pres-
ence of Ca2+, STK24 strongly inhibited the binding both in the
presence and absence of Ca2+ (Figure 5A) and abrogated most
of the stimulatory effect of Ca2+ on the binding (Figure 5B).
Boswell et al. (2012) have shown that UNC13D bound to lipo-
somes via its C2B domain in a Ca2+-sensitive manner. We found
that mutating the two Ca2+-binding Asp residues (941 and 947)
into Asn in the C2B domain not only abrogated Ca2+-stimulated
binding of UNC13D to liposomes as Boswell et al. (2012) showed
(Figure S5A), but also attenuated the interaction of UNC13D with
STK24 (Figure 5C). This result suggests that these Asp residues
may be involved in Ca2+-mediated regulation of UNC13DbindingDevelopmto both lipids and STK24. Consistent with this conclusion,
STK24, via its kinase domain, interacted with the C2B domain
in a coimmunoprecipitation assay (Figures S5B–S5D) and
pull-down assay using recombinant proteins (Figures 5D and
S5E). In addition, STK24 without this kinase domain, unlike
WT STK24, was not able to revert STK24 deficiency-inducedental Cell 27, 215–226, October 28, 2013 ª2013 Elsevier Inc. 219
Figure 5. STK24 Inhibits UNC13D Binding to Liposomes
(A and B) STK24, but not CCM3, inhibits UNC13D binding to liposomes. Re-
combinant UNC13D (33 nM) and STK24 (66 nM) or CCM3 (66 nM) were
incubated with liposomes. After ultracentrifugation, liposome layers and inputs
were analyzed by western blotting (A). The ratios of UNC13D contents in the
liposome layers in the presence of Ca2+ to those in the presence of EGTA
(Ca2+) were obtained from quantification of the blots from three independent
experiments (B) and are shown as means ± SD (*p < 0.01; Student’s t test).
(C) Ca2+-binding site mutations in UNC13DC2B domain disrupt the interaction
with STK24. GST pull-down was carried out using recombinant protein as
indicated in the presence of Ca2+ or EGTA (Ca2+). Proteins were detected by
western analysis. C2B*, UNC13D C2B mutant (D941N, D947N). See also
Figure S5A.
(D) Direct interaction between SKT24 and UNC13D C2B. A pull-down assay
was carried out using recombinant proteins (40 nM C2B and 40 nM STK24),
which was detected by Coomassie Blue staining. See also Figures S5–S5F.
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STK24 and CCM3 Regulate Exocytosisincrease in MPO release (Figure S5F), underscoring the impor-
tance of STK24-UNC13D C2B interaction in STK24-mediated
suppression of exocytosis. Therefore, putting these results
together, we conclude that STK24 may compete with lipids for
binding to the C2B domain.
CCM3 Counteracts STK24 in UNC13 Binding to
Liposomes
Although CCM3 alone had little effect on UNC13D-liposome
binding (Figures 5A and 5B), it unexpectedly attenuated the inhi-
bition of UNC13D-liposome binding by STK24 (Figure 6A). More-
over, this attenuation was much greater in the presence of Ca2+
than in its absence, because there was significantly greater
Ca2+-induced liposome binding of UNC13D in the presence of
CCM3 than that in the presence of STK24 alone (Figure 6B). In
other words, CCM3 appears to have a role in restoring Ca2+-
sensitivity suppressed by STK24. Given that chemoattractants
increase intracellular Ca2+ concentrations, this finding may un-220 Developmental Cell 27, 215–226, October 28, 2013 ª2013 Elsevderlie a mechanism by which degranulation of the reserved
granule pool is regulated by chemoattractants.
One possible way for CCM3 to counteract STK24-mediated
inhibition is to disrupt the interaction between STK24 and
UNC13D. Contrary to this possibility, the presence of CCM3
did not disrupt the STK24-UNC13D interaction (compare lanes
2 and 4 of Figure 6C), but rather markedly enhanced the interac-
tionwhenCa2+waspresent (compare lanes 3 and5of Figure 6C).
Because CCM3 interacts with UNC13D N-terminal (NT) region
that contains the C2A domain (Figures S5B and S6A), we
mutated two of the Ca2+-binding Asp residues (127 and 133)
into Asn in this domain. Although these mutations did not affect
Ca2+-dependent liposome binding (Figure S5A) as previously re-
ported (Boswell et al., 2012), they, unlike those in the C2B
domain that disrupt the interaction with STK24 (Figure 5C), unex-
pectedly augmented the interaction with CCM3 (Figure 6D). We
do not understand the effect of these C2Amutations on the inter-
action. One simple explanation is that the mutated domain may
mimic the Ca2+-bound state, given that Ca2+ also enhanced the
interaction of UNC13Dwith CCM3 (Figure 6D). Nevertheless, this
UNC13D mutant can help us to understand how CCM3 and
its interaction with UNC13D are involved in counteracting
STK24’s effect. Thus, we tested the effect of these C2A muta-
tions on CCM3-mediated reversal of the inhibition by STK24.
UNC13D carrying these C2Amutations appeared to bind to lipo-
somes as strongly in the absence of Ca2+ as theWTUNC13D did
in the presence of Ca2+ in the liposome-binding assay in which
both STK24 and CCM3 were present (compare lanes 1 and 4
of Figure 6E). In addition, the interaction of this mutant, unlike
the WT UNC13D, with liposomes was largely insensitive to
Ca2+ (compare the difference between lanes 3 and 4 with that
between lanes 1 and 2 in Figure 6E). These results indicate a cor-
relation between greater interaction of CCM3 with UNC13D,
which can be the result of either increased Ca2+ concentration
or the mutations in the C2A domain, and stronger reversal of
STK24-mediated inhibition of UNC13D binding to liposomes.
This correlation can be further interpreted to suggest that the
enhanced interaction of CCM3 with UNC13D, which is mediated
by the C2A domain, might be an important step in Ca2+-stimu-
lated CCM3-mediated relief of STK24 inhibition of UNC13D-lipo-
some binding. Together with the knowledge of the interactions
between CCM30s NT domain and STK24’s CT domain (Ceccar-
elli et al., 2011) and between CCM3’s FATH domain and
UNC13DN terminus (Figure S6A), we propose amodel to explain
how ligand/Ca2+may regulate exocytosis through theCCM3 and
STK24 complex (Figure 6F). In this model, STK24 binds to
UNC13D C2B domain to inhibit UNC13D binding to liposomes
at the resting state. When Ca2+ concentration arises upon ligand
stimulation, Ca2+ binds to UNC13D C2B domain and stimulates
the binding of the C2B domain to liposomes on one hand. On the
other hand, Ca2+ binds to the C2A domain and enhances the
interaction of the C2A domain with CCM3. The binding of
CCM3 to the C2A domain may recruit STK24 away from its bind-
ing to the C2B domain, thus relieving STK24-mediated inhibition
of liposome binding. This model is supported by the findings that
Ca2+ augmented the formation of a ternary complex of UNC13D
C2A domain with CCM3 and STK24 (Figure 6G) and that the
CCM3 mutant that cannot interact with STK24 failed to reverse
STK24-mediated inhibition of lipid binding (Figure S6B).ier Inc.
Figure 6. Ca2+ Stimulates CCM3-UNC13D
Interaction to Relieve the Inhibition by
STK24
(A and B) CCM3 counteracts STK24-mediated
inhibition of UNC13D binding to liposomes.
Recombinant UNC13D (33 nM), STK24 (66 nM),
and CCM3 (66 nM) were incubated with lipo-
somes. After ultracentrifugation, liposome layers
and inputs were analyzed by western blotting (A).
The ratios of UNC13D contents in the liposome
layers in the presence of Ca2+ to those in the
presence of EGTA (-Ca2+) were obtained from
quantification of the blots from three independent
experiments (B) and are shown as means ± SD
(*p < 0.01; Student’s t test). See also Figure S6A.
(C) Ca2+ stimulates the formation of UNC13D,
CCM3 and STK24 complex. GST pull-down was
carried out using recombinant proteins as indi-
cated in the presence of Ca2+ or EGTA (-Ca2+).
Proteins were detected by western analysis.
(D) Ca2+-binding site mutations in UNC13D C2A
domain enhance the interaction with CCM3. GST
pull-down was carried out using recombinant
proteins as indicated in the presence of Ca2+ or
EGTA (-Ca2+). C2A* stands for the UNC13D
mutant carrying the D127N and D133N mutations.
Proteins were detected by western analysis.
(E) Ca2+-binding site mutations in UNC13D C2A
domain enhance liposome binding. Recombinant
proteins were incubated with liposomes in the
presence of Ca2+ or EGTA (-Ca2+). After ultracen-
trifugation, liposome layers and inputs were
analyzed by western blotting. Blots from three in-
dependent experiments were quantified, and the
value forWT binding alone (Lane 6) was taken as 1.
The data are shown as means ± SD (AU, arbitrary
unit; *p < 0.05, Student’s t test).
(F) A model depicting the regulation of degranu-
lation of the reserved granule pool by STK24 and
CCM3 in response to Ca2+. At the basal state,
STK24 binds to the C2B domain of UNC13D and
inhibits its binding to the plasma membrane lipid.
When cells are stimulated, the intracellular Ca2+
concentrations increase. Ca2+ stimulates the
interaction of UNC13D C2A domain with CCM3,
which presumably leads to a reduction in STK24
binding to UNC13D at the C2B domain and hence
STK24-mediated inhibition of UNC13D binding to
lipid and granule docking/priming. F, FATH
domain; NT, N-terminal domain; CT, C-terminal
domain; K, kinase domain. See also Figure S6B.
(G) Effect of Ca2+ on the formation of the ternary
complex of UNC13D C2A domain (C2A), CCM3,
and STK24. GST pull-down was carried out
using recombinant proteins (20 nM C2A, 40 nM
CCM3, and 40 nM STK24) in the presence or of
Ca2+ or EGTA (Ca2+) and detected by Coo-
massie staining.
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an Ischemia-Reperfusion Model
We next examined the in vivo significance of enhanced degran-
ulation associated with the loss of STK24 or CCM3. A renal
ischemia-reperfusion injury model was adopted, because neu-
trophils are important for the reperfusion-induced renal tissue
damage (Heinzelmann et al., 1999). Reperfusion after renal arte-Developmrial ischemia resulted in infiltration of neutrophils (Figures S7A
and S7B). Importantly, the reperfusion induced significantly
greater increases in serum creatinine contents (Figures 7A and
7B) and the number of coagulative necrotic renal tubules (Fig-
ures 7C–7F) in both Stk24h/h and Ccm3m/m mice than their
wild-type controls. These results indicated that the lack of
STK24 or CCM3 was associated with increased renal tissueental Cell 27, 215–226, October 28, 2013 ª2013 Elsevier Inc. 221
Figure 7. Loss of STK24 or CCM3 Exacerbates Tissue Damages in a
Renal Ischemia-Reperfusion Model
(A and B) Blood creatinine contents frommice that were subjected to the renal
ischemia-reperfusion procedure. Data are presented as means ± SEM (*p <
0.05, Student’s t test, n = 4).
(C–F) Histological examination of renal tissue injury. Renal histological sections
from mice that were subjected to the renal ischemia-reperfusion procedure
were stained with periodic acid-Schiff (PAS) dye, and the representative
sections are shown (C and D). The numbers of coagulative necrotic tubules
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deficiency did not significantly affect the numbers of neutrophils
infiltrated into the kidneys (Figures S7C and S7D), augmented
tissue damage occurred in these mutant mice should be at least
in part attributed to the enhanced degranulation. In support of
this idea, we found that there were significantly higher levels of
plasma MPO in the STK24 or CCM3 mutant mice than their con-
trols (Figures 7G and 7H).
DISCUSSION
In this study, we have uncovered an important cellular function
for the protein complex of CCM3 and one of the GCK III subfam-
ily members, STK24. We present solid evidence to demonstrate
that the protein complex plays significant roles in ligand-stimu-
lated exocytosis in neutrophils. Importantly, we have character-
ized the biochemical mechanism by which CCM3 and STK24
regulate this cellular function.
Most of the work on ligand-stimulated exocytosis has been
done with neurons, endocrine cells, platelets, and cytotoxic
T cells. Not much is known about the mechanisms for ligand-
regulated exocytosis or degranulation in neutrophils, other than
the involvement of UNC13D and RAB27 (Munafo´ et al., 2007;
Brzezinska et al., 2008; Herrero-Turrio´n et al., 2008; Pivot-Pajot
et al., 2008; Elstak et al., 2011). In this study, we found that
MPO secretion had at least two phases. The first phase probably
corresponds to the release of the readily releasable pool, which is
rapidly released upon ligand stimulation, whereas the second
phase may be from the reserved pool, which may not be docked
prior to the initial stimulation. The STK24-CCM3 complex seems
to primarily regulate the release of the reserved pool. This conclu-
sion is consistent with our mechanistic results, which show that
STK24 appears to regulate steps upstream of vesicle fusion,
because its deficiency doesn’t affect vesicle fusion kinetics. In
further support of this conclusion, STK24 inhibits the binding of
UNC13D to lipids, a step that is important for vesicle docking
(Pivot-Pajot et al., 2008; Boswell et al., 2012). The involvement
of CCM3 in exocytosis regulation seems more complicated
than that of STK24. CCM3 appears to play dual roles. On one
hand, it stabilizes the STK24 protein. This may explain the similar
degranulation phenotypes of its deficiency to those of STK24
deficiency. On the other hand, CCM3 is required for restoration
ofCa2+-stimulated binding of UNC13D to lipids that is strongly in-
hibited by STK24. This restoration provides a means for ligands
that can increase intracellular Ca2+ concentrations to regulate
the secondphase of degranulation from the reserved pool, as de-
picted in themodel (Figure 6F). In this model, Ca2+ stimulates the
interaction of CCM3 with UNC13D C2A domain, which recruits
STK24 away from the C2B domain to allow the binding of the
C2B domain to lipids. We, however, do not know exactly why
the lack of either STK24 or CCM3 did not significantly impact
the first phase of exocytosis immediately after ligand stimulation.were counted from six random PAS-stained sections per kidney and are
presented as means ± SEM (*p < 0.05, Student’s t test, n = 4).
(G and H) Blood MPO contents from mice that were subjected to the renal
ischemia-reperfusion procedure. Data are presented as means ± SEM (*p <
0.05, Student’s t test, n = 4).
See also Figure S7.
ier Inc.
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and membrane lipids for binding to UNC13D C2B domain may
have been reached at the resting state.
Our renal ischemia-reperfusion model study of STK24-defi-
cient and particularly myeloid-specific CCM3-deficient mice
has demonstrated the in vivo significance of this degranulation
regulation imposed by the STK24 and CCM3 complex. Given
the broad tissue expression patterns of CCM3 and GCKIII
subfamily members, these proteins may also be involved in
the regulation of exocytosis in other cell types. This may be
particularly important for the understanding of the regulation
of the second phase of exocytosis from the reserved pool,
because the mechanism for this regulation remains largely
elusive (Sugita, 2008; Pores-Fernando and Zweifach, 2009;
Seino et al., 2011). Another potential impact of this study may
be on the investigation of the pathogenic basis by which
CCM3 mutations cause the CCM disease. Our preliminary evi-
dence suggests that CCM3 and STK24 are also involved in
the regulation of endothelial cell exocytosis. Knockdown of
CCM3 or STK24 resulted in an increase in the level of cell sur-
face P-selectin upon TNFa stimulation without altering the
mRNA levels of P-selectin (data not shown). P-selectin is a
cell surface adhesion molecule and stored in endothelial gran-
ules called Weibel-Palade bodies (WPBs). It is transported to
cell surfaces through exocytosis in response to stimulation by
proinflammatory ligands including TNFa (Valentijn et al., 2011).
This preliminary observation not only indicates the importance
of this protein complex in exocytic regulation beyond neutro-
phils, but also provides a basis for a plausible hypothesis to
explain the contribution of CCM3 inactivation to the CCM
pathogenesis. We hypothesize that enhanced exocytosis in
response to certain stimulations in the brain may contribute to
vascular defects observed in CCM disease. It is not difficult to
postulate how enhanced exocytosis, through which cell surface
and secreted proteins and molecules are transported to their
functional sites, causes the vasculature defects. For instance,
enhanced release of angiopoietin-2, which is also stored from
WPBs, may cause capillary destabilization (Augustin et al.,
2009), whereas increased levels of cell adhesion or junction pro-
teins may result in defects in the formation and maintenance of
vessel tubular morphology. This hypothesis is also compatible
for the anatomic restriction of the CCM lesions, which may be
the result of the unique nature of the stimulations and/or effect
of hyperexocytic activity on the blood vessels in the brain.
Therefore, more studies are warranted to further characterize
the role of CCM3 and STK24 as well as other members of the
GCKIII subfamily in endothelial cell exocytosis and determine
if altered exocytosis contributes to the CCM phenotypes. Of
note, our hypothesis is consistent with the findings from a recent
fly genetic study. This fly work shows that the loss-of-function
mutants of fly CCM3 or GCKIII kinase ortholog have dilated
tracheal tubes, which resemble dilated vessels found in CCM
patients. This tube dilation phenotype can be suppressed by
the reduction in the expression of N-ethylmaleimide sensitive
factor 2 (NSF2) (Song et al., 2013). Given the important role of
NSF2 in SNARE recycling and the secondary phase of exocy-
tosis (Zhao et al., 2012), these fly results are in agreement
with our observation that the STK24-CCM3 complex regulates
exocytosis of the reserved pool of granules and support our hy-Developmpothesis that enhanced exocytosis may contribute to defective
vessel tubular morphology observed in the CCM disease.
Despite the shared heart development phenotypes in zebra-
fish (Zheng et al., 2010) and exocytosis in cultured endothelial
cells by CCM3 and STK24 knockdown, we have not observed
overt cardiac or consistent vascular defects in the Stk24h/h
mice. The lack of the obvious cardiovascular phenotypes may
be attributed to greater molecular redundancy of the GCKIII sub-
family members in mice, which is consistent with the weaker
effect of STK24 knockdown on P-selectin cell surface expres-
sion than CCM3 knockdown (data not shown). Alternatively,
exocytosis may only be one of many cellular activities regulated
by CCM3, as CCM3 was found to regulate Golgi assembly with
STK25 (Fidalgo et al., 2010). These questions need to be
resolved in future investigation.
EXPERIMENTAL PROCEDURES
Reagents and Constructs
CCM3 antibody was generated as described before (He et al., 2010). Other
antibodies were acquired commercially: STK24 antibodies (rabbit, 3723,
Cell Signaling), GST antibody (2624, Cell Signaling), His antibody (2366,
Cell Signaling), MST4 antibody (3822, Cell Signaling), HA antibody (MMS-
101R, Covance), Myc antibody (MMS-150R, Covance), GFP antibody
(sc-9996, Santa Cruz Biotechnology), Gb2 antibody (sc-380, Santa Cruz
Biotechnology), and MPO antibody (HM1051BT, HyCult Biotech). Protein
A/G-PLUS-agarose beads were acquired from Santa Cruz Biotechnology.
Formyl-Met-Leu-Phe (fMLP) and Cytochalasin B (CB) were purchased from
Sigma. Human UNC13D cDNA, and mouse STK24 cDNA were acquired
from Open Biosystems.
Mice
STK24h/hmice were generated using a gene-trap ESC line AM0826 (Wellcome
Trust Sanger Institute) from International Gene Trap Consortium at the
Mutant Mouse Regional Resource Center (UC Davis) using the standard
method. Mice heterozygous for the mutation were initially generated on a
mixed 129/Ola and C57BL/6 background and were subsequently back-
crossed to the C57BL/6 background for more than five generations.
Myeloid-specific CCM3 knockout mice were generated by crossing floxed
CCM3 mice (He et al., 2010) with the B6.129-Lyzstm1(cre)Ifo/J mice from Jack-
son Lab. All animal studies were approved by the Institutional Animal Care and
Use Committees of Yale University.
White Blood Cell Counts
A Hemavet system (Drew Scientific), which is a multiparameter, automated
hematology analyzer designed for in vitro diagnostic use (Li et al., 2009),
was used to count the leukocyte numbers in circulating blood. To quantify
neutrophil numbers in spleens, livers, and kidneys, cells were dissociated
from the tissues and total cell numbers were counted using a Guava
EasyCyte System (Millipore). The cells were also stained with APC-CD11b
antibody (17-0112, eBioscience) and Percp-Ly-6G (560602, BD) antibody
and analyzed by a LSR II FACS analyzer. Neutrophils were defined as Ly-
6G+CD11b+ cells.
Neutrophil Preparation and Transfection
Murine neutrophils were purified from bone marrows as previously described
(Zhang et al., 2010). Briefly, bone marrow cells collected from mice were
treated with the ACK buffer (155 mM NH4Cl, 10 mM KHCO3 and 127 mM
EDTA) for red blood cell lysis, followed by a discontinuous Percoll density
gradient centrifugation. Neutrophils were collected from the band located
between 81% and 62% of Percoll. For transient transfection of primary mouse
neutrophils, three million neutrophils were electroporated with 1.6 mg endo-
toxin-free plasmids using the human monocyte nucleofection kit (Lonza)
with an Amaxa electroporation system. The cells were then cultured for
overnight in the medium supplied with the kit containing 10% FBS andental Cell 27, 215–226, October 28, 2013 ª2013 Elsevier Inc. 223
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FACS Aria sorter (BD).
Immunostaining of Neutrophils
Neutrophils were placed onto the coverslips for 15 min before stimulation. The
cells were then fixed with 4% paraformaldehyde and permeabilized with
0.01% saponin and blocked with 2% BSA in PBS (Brzezinska et al., 2008).
Neutrophils were stained with a STK24 antibody (3723, Cell Signaling, 1:100)
and/or biotinylated MPO antibody (HM1051BT, Hycult Biotech, 1:100), fol-
lowed by Alexa-488-Goat-anti-Rabbit (Invitrogen, 1:300 for the STK antibody)
and APC-streptavidin (BD, 1:300 for the MPO antibody) staining using a previ-
ously described protocol (Xu et al., 2010). Mounted slideswere observed using
a Leica SP5 confocal microscopy.
TIRF Microscopy
TIRF imaging was performed using an IX-70 inverted microscope (Olympus),
equipped with argon (488 nm) and argon/krypton (568 nm) laser lines (Melles
Griot), a 603 1.45 NA oil immersion objective lens (Plan-ApoN; Olympus),
and a custom TIRFM condenser. Cells were imaged in one channel at
5–10 Hz or two channels by sequential excitation at 3–5 Hz without binning
and detected with a back-illuminated iXon887 EMCCD camera (512 3 512,
0.18 mm per pixel, 16 bits; Andor Technologies) with a 1.63 magnification
lens. The system was controlled by the Andor iQ software (Xu et al., 2011).
For live-cell imaging, neutrophils were resuspended in 2 ml Hank’s buffer
with 0.25% BSA and seeded into 35 mm Petri dish with a No. 1.5 coverglass
at the bottom (MatTek). For cell stimulation, an Eppendorf Femotip was loaded
with 50 mM fMLP and 50 mMCB, and ligands were loaded by applying air pres-
sure to the micropipette using a Picospritzer II microinjection system (Parker
Hannifin). Each puff lasts 1 s, and the volume for each puff is 5 nl. Time-
lapsed images were acquired at 200 ms intervals at 37C. For fixed cell imag-
ing, neutrophils were stimulated with 1 mM fMLP and 10 mM CB, fixed, and
stained with anti-MPO antibody (HyCult Biotech) before imaging.
MPO and MMP Detection
Onemillion neutrophils were incubatedwith 10 mMCB for 5min at 37Cprior to
stimulation with fMLP (500 nM) or MIP2 (10 nM) for another 10 min. The reac-
tion was stopped by being placed on ice, and the suspension was centrifuged
at 500 3 g for 5 min at 4C. Supernatants were assayed for MPO and MMP
contents using the EnzChek Myeloperoxidase Activity Assay Kit and EnzChek
Gelatinase/Collagenase Assay kit (Life Technologies), respectively (Lee et al.,
2007; Li et al., 2009).
Immunoprecipitation
HEK293T cells were maintained in Dulbecco’s modified Eagle’s medium
(DMEM) with 4.5 g/liter glucose supplemented with 10% fetal bovine serum
(FBS). Transient transfection was carried out using Lipofectamine Plus (Life
Technologies), and samples were collected 24 hr after transfection. Cells
were lysed in a cell lysis buffer (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1%
NP-40, 5 mM EDTA, Roche’s protease inhibitor cocktail, Roche’s phospha-
tase inhibitor cocktail). After removing insoluble materials by centrifugation,
immunoprecipitation was carried out by adding various antibodies and
Protein A/G-PLUS-agarose beads into supernatants. Immunocomplexes
were washed three times with lysis buffer before the SDS sample buffer was
added for SDS-PAGE analysis.
Phagocytosis, Chemotaxis, and Superoxide Production Assays
For testing phagocytosis, neutrophils (0.5 million) were incubated with 20 ml
pHrodo Escherichia coli BioParticles Conjugate (Invitrogen) at 37C. After fix-
ation, cells were analyzed by flow cytometry using a BD LSRII FACS analyzer
(Hsieh et al., 2009).
The chemotaxis assay was carried out using a Dunn chamber as previously
described (Zicha et al., 1997) with some modifications as detailed in (Xu et al.,
2010; Zhang et al., 2010).
For superoxide production assay, neutrophils were suspended in Hank’s
buffer at 1 3 106/ml on ice. Fifty microliters of cells were mixed with 20 ml
HRP (100 U/ml, Sigma), 1.5 ml luminol (10 mM, Sigma), and 28.5 ml Hank’s
buffer in a well of a 96-well plate. Chemiluminescence was detected by a
Wallac plate reader (Dong et al., 2005).224 Developmental Cell 27, 215–226, October 28, 2013 ª2013 ElsevTAP and Mass Spectrometry Analyses
TAP were performed with the InterPlay Mammalian TAP System (Agilent). The
purified proteins were separated on SDS-PAGE, and the protein bands were
excised from the gel for MS analyses. An LTQ-Orbitrap was used for identifi-
cation of CCM3 and STK24-associated proteins at W.M. Keck MS and Prote-
omics Resource of Yale University. MS/MS spectra were searched against
Homo sapiens subset of the National Center for Biotechnology Information
(NCBI) protein sequence database (Release 20110610) usingMascot Daemon
software.
Protein Preparation and Pull-Down
Recombinant proteins were expressed in E. coli BL21(DE3) and purified by
affinity chromatography using glutathione agarose beads for GST-fusion pro-
teins or Ni-NTA agarose beads (GE Healthcare) for His-tagged proteins. Pro-
teins were dialyzed to a buffer containing 20 mM HEPES, pH 7.5, 100 mM
KCl, 0.1% Triton X-100, 0.2 mM EGTA, 10% glycerol, and 1 mM DTT. For
the pull-down assays, His- and GST-tagged proteins were incubated with
either glutathione-agarose or Ni-NTA agarose beads as indicated in the figures
at 4C for 5 hr. After extensive washes, proteins on the beads were resolved by
SDS/PAGE and detected by western blot or Coomassie blue staining.
Buoyant Density Flotation of Liposome Assay
The assay was performed as previously described (Boswell et al., 2012). Lipo-
somes were consisted of 85% PC and 15% PS which were purchased from
Avanti Polar Lipids and were incubated with UNC13D and indicated proteins
(BSA or STK24/CCM3) for 30 min on ice in 75 ml of 25 mM HEPES, pH 7.4,
100 mM KCl, 10% glycerol, and 1 mM DTT (reconstitution buffer). Liposomes
binding reactions were conducted in the absence of Ca2+ (0.2 mM EGTA) or
presence of 100 mM of free Ca2+. 75 ml of 80% Accudenz was added to
the binding reaction to yield a final concentration of 40% Accudenz. Thirty
percent Accudenz and reconstitution buffers were then layered on top and
centrifuged for 4 hr in a TLA100 rotor at 32,000 rpm. Either the floated fraction
or inputs were collected and run on SDS-PAGE and analyzed by western
blotting.
Murine Kidney Ischemia/Reperfusion Models
The left and right renal arteries of mutant and their littermate control mice
(9–10weeks old) were clamped for 30min using vascular clamps (Fine Science
Tools) through a midline abdominal incision under general anesthesia. After
ischemia, the clamps were removed, the wounds were sutured, and the ani-
mals were allowed to recover for 24 hr before euthanization. Blood was
collected by cardiac puncture in heparin-containing tube, and creatinine levels
were determined using the DetectX serum creatinine kit (Arbor Assays). Kid-
neys were dissected from mice, fixed in 4% paraformaldehyde, embedded
in paraffin, and stained for the periodic acid-Schiff (PAS) dye and a Ly6B
antibody. Plasma MPO levels were determined using an ELISA kit (HyCult
Biotechnology).
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